SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 411 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,868,996 | +34.7% | 62,462 | +10.4% | 0.02% | +38.5% |
Q1 2024 | $7,324,717 | -41.5% | 56,579 | -56.4% | 0.01% | -50.0% |
Q4 2023 | $12,520,568 | +90.0% | 129,841 | +138.8% | 0.03% | +52.9% |
Q3 2023 | $6,590,489 | +37.2% | 54,368 | +29.6% | 0.02% | 0.0% |
Q2 2023 | $4,802,511 | -38.5% | 41,936 | -25.9% | 0.02% | -85.5% |
Q1 2023 | $7,805,175 | -6.6% | 56,629 | -12.2% | 0.12% | -23.0% |
Q4 2022 | $8,353,893 | +190.7% | 64,469 | +148.0% | 0.15% | +176.4% |
Q3 2022 | $2,874,000 | -31.1% | 26,000 | -51.3% | 0.06% | -50.5% |
Q1 2022 | $4,169,000 | +111.6% | 53,361 | +144.0% | 0.11% | +82.0% |
Q4 2021 | $1,970,000 | +401.3% | 21,873 | +415.0% | 0.06% | +454.5% |
Q3 2021 | $393,000 | -53.3% | 4,247 | -62.4% | 0.01% | -77.6% |
Q1 2021 | $841,000 | -77.1% | 11,282 | -60.4% | 0.05% | -79.4% |
Q4 2019 | $3,678,000 | +232.2% | 28,500 | +93.9% | 0.24% | +260.6% |
Q3 2019 | $1,107,000 | -34.4% | 14,700 | +32.3% | 0.07% | -64.3% |
Q2 2019 | $1,688,000 | – | 11,111 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |